HomeTRVI • NASDAQ
Follow
Trevi Therapeutics Inc
Previous close
$3.47
Day range
$3.39 - $3.54
Year range
$0.97 - $4.00
Market cap
237.91M USD
Avg Volume
389.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.04M | 7.61% |
Net income | -7.70M | 6.87% |
Net profit margin | — | — |
Earnings per share | -0.08 | 33.33% |
EBITDA | -9.01M | -7.31% |
Effective tax rate | 0.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.87M | -29.25% |
Total assets | 95.90M | -25.29% |
Total liabilities | 6.29M | -65.94% |
Total equity | 89.61M | — |
Shares outstanding | 63.86M | — |
Price to book | 2.48 | — |
Return on assets | -22.97% | — |
Return on capital | -24.11% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -7.70M | 6.87% |
Cash from operations | -7.28M | 15.12% |
Cash from investing | 17.98M | 470.76% |
Cash from financing | 1.51M | -97.27% |
Net change in cash | 12.21M | -70.84% |
Free cash flow | -4.68M | 10.29% |
About
Founded
2011
Headquarters
Website
Employees
25